239 related articles for article (PubMed ID: 22436135)
1. Proton and carbon ion radiotherapy for primary brain tumors delivered with active raster scanning at the Heidelberg Ion Therapy Center (HIT): early treatment results and study concepts.
Rieken S; Habermehl D; Haberer T; Jaekel O; Debus J; Combs SE
Radiat Oncol; 2012 Mar; 7():41. PubMed ID: 22436135
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcome after particle therapy for meningiomas of the skull base: toxicity and local control in patients treated with active rasterscanning.
El Shafie RA; Czech M; Kessel KA; Habermehl D; Weber D; Rieken S; Bougatf N; Jäkel O; Debus J; Combs SE
Radiat Oncol; 2018 Mar; 13(1):54. PubMed ID: 29587795
[TBL] [Abstract][Full Text] [Related]
3. Prospective evaluation of early treatment outcome in patients with meningiomas treated with particle therapy based on target volume definition with MRI and 68Ga-DOTATOC-PET.
Combs SE; Welzel T; Habermehl D; Rieken S; Dittmar JO; Kessel K; Jäkel O; Haberkorn U; Debus J
Acta Oncol; 2013 Apr; 52(3):514-20. PubMed ID: 23402336
[TBL] [Abstract][Full Text] [Related]
4. Volumetric response of intracranial meningioma after photon or particle irradiation.
Mozes P; Dittmar JO; Habermehl D; Tonndorf-Martini E; Hideghety K; Dittmar A; Debus J; Combs SE
Acta Oncol; 2017 Mar; 56(3):431-437. PubMed ID: 27911139
[TBL] [Abstract][Full Text] [Related]
5. Proton and carbon ion radiotherapy for primary brain tumors and tumors of the skull base.
Combs SE; Kessel K; Habermehl D; Haberer T; Jäkel O; Debus J
Acta Oncol; 2013 Oct; 52(7):1504-9. PubMed ID: 23962241
[TBL] [Abstract][Full Text] [Related]
6. Sequential proton boost after standard chemoradiation for high-grade glioma.
Adeberg S; Bernhardt D; Harrabi SB; Uhl M; Paul A; Bougatf N; Verma V; Unterberg A; Wick W; Haberer T; Combs SE; Herfarth K; Debus J; Rieken S
Radiother Oncol; 2017 Nov; 125(2):266-272. PubMed ID: 29050959
[TBL] [Abstract][Full Text] [Related]
7. Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: the CLEOPATRA trial.
Combs SE; Kieser M; Rieken S; Habermehl D; Jäkel O; Haberer T; Nikoghosyan A; Haselmann R; Unterberg A; Wick W; Debus J
BMC Cancer; 2010 Sep; 10():478. PubMed ID: 20819220
[TBL] [Abstract][Full Text] [Related]
8. Heidelberg Ion Therapy Center (HIT): Initial clinical experience in the first 80 patients.
Combs SE; Ellerbrock M; Haberer T; Habermehl D; Hoess A; Jäkel O; Jensen A; Klemm S; Münter M; Naumann J; Nikoghosyan A; Oertel S; Parodi K; Rieken S; Debus J
Acta Oncol; 2010 Oct; 49(7):1132-40. PubMed ID: 20831505
[TBL] [Abstract][Full Text] [Related]
9. Assessment of early toxicity and response in patients treated with proton and carbon ion therapy at the Heidelberg ion therapy center using the raster scanning technique.
Rieken S; Habermehl D; Nikoghosyan A; Jensen A; Haberer T; Jäkel O; Münter MW; Welzel T; Debus J; Combs SE
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e793-801. PubMed ID: 21300464
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of particle radiotherapy for the re-irradiation of recurrent intracranial meningioma.
El Shafie RA; Czech M; Kessel KA; Habermehl D; Weber D; Rieken S; Bougatf N; Jäkel O; Debus J; Combs SE
Radiat Oncol; 2018 May; 13(1):86. PubMed ID: 29739417
[TBL] [Abstract][Full Text] [Related]
11. Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: the CINDERELLA trial.
Combs SE; Burkholder I; Edler L; Rieken S; Habermehl D; Jäkel O; Haberer T; Haselmann R; Unterberg A; Wick W; Debus J
BMC Cancer; 2010 Oct; 10():533. PubMed ID: 20925951
[TBL] [Abstract][Full Text] [Related]
12. First experiences in treatment of low-grade glioma grade I and II with proton therapy.
Hauswald H; Rieken S; Ecker S; Kessel KA; Herfarth K; Debus J; Combs SE
Radiat Oncol; 2012 Nov; 7():189. PubMed ID: 23140402
[TBL] [Abstract][Full Text] [Related]
13. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
[TBL] [Abstract][Full Text] [Related]
14. Analysis of FET-PET imaging for target volume definition in patients with gliomas treated with conformal radiotherapy.
Rieken S; Habermehl D; Giesel FL; Hoffmann C; Burger U; Rief H; Welzel T; Haberkorn U; Debus J; Combs SE
Radiother Oncol; 2013 Dec; 109(3):487-92. PubMed ID: 23953407
[TBL] [Abstract][Full Text] [Related]
15. Carbon ion radiotherapy boost in the treatment of glioblastoma: a randomized phase I/III clinical trial.
Kong L; Gao J; Hu J; Lu R; Yang J; Qiu X; Hu W; Lu JJ
Cancer Commun (Lond); 2019 Feb; 39(1):5. PubMed ID: 30786916
[TBL] [Abstract][Full Text] [Related]
16. Comparison of intensity modulated radiotherapy (IMRT) with intensity modulated particle therapy (IMPT) using fixed beams or an ion gantry for the treatment of patients with skull base meningiomas.
Kosaki K; Ecker S; Habermehl D; Rieken S; Jäkel O; Herfarth K; Debus J; Combs SE
Radiat Oncol; 2012 Mar; 7():44. PubMed ID: 22439607
[TBL] [Abstract][Full Text] [Related]
17. Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy.
Mizoe JE; Tsujii H; Hasegawa A; Yanagi T; Takagi R; Kamada T; Tsuji H; Takakura K;
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):390-6. PubMed ID: 17459607
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and toxicity of particle radiotherapy in WHO grade II and grade III meningiomas: a systematic review.
Wu A; Jin MC; Meola A; Wong HN; Chang SD
Neurosurg Focus; 2019 Jun; 46(6):E12. PubMed ID: 31153145
[TBL] [Abstract][Full Text] [Related]
19. Particle radiation therapy in the management of malignant glioma: Early experience at the Shanghai Proton and Heavy Ion Center.
Kong L; Wu J; Gao J; Qiu X; Yang J; Hu J; Hu W; Mao Y; Lu JJ
Cancer; 2020 Jun; 126(12):2802-2810. PubMed ID: 32167589
[TBL] [Abstract][Full Text] [Related]
20. Raster-scanned carbon ion therapy for malignant salivary gland tumors: acute toxicity and initial treatment response.
Jensen AD; Nikoghosyan AV; Ecker S; Ellerbrock M; Debus J; Herfarth KK; Münter MW
Radiat Oncol; 2011 Nov; 6():149. PubMed ID: 22046954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
